
Dextromethorphan Hydrobromide (10mg/10ml) + Ambroxol (30mg/5ml) + Phenylephrine (15mg/5ml) + Cetirizine (5mg/5ml) + Guaifenesin (100mg/5ml)
Active composition
+4 more active ingredients
Dextromethorphan acts on the cough center in the brain, reducing the urge to cough.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Cetirizine acts as a competitive antagonist of histamine H1 receptors, thereby reducing the effects of histamine and alleviating allergic symptoms.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
Winituss-DMR Tablet is a combination medication formulated to provide comprehensive relief from symptoms associated with respiratory tract infections and allergic conditions. It contains Ambroxol (30mg/5ml), a mucolytic agent that facilitates the breakdown and clearance of mucus, thereby improving airway patency. Cetirizine (5mg/5ml), a second-generation antihistamine, effectively alleviates allergic symptoms such as sneezing, runny nose, and itching by selectively inhibiting peripheral H1 receptors. Dextromethorphan Hydrobromide (10mg/10ml) acts as a centrally acting antitussive, suppressing the cough reflex to reduce the frequency and severity of dry, non-productive cough. Guaifenesin (100mg/5ml) serves as an expectorant, promoting the loosening and expulsion of mucus from the respiratory tract, enhancing productive cough. Phenylephrine (15mg/5ml), a selective alpha-1 adrenergic receptor agonist, provides symptomatic relief from nasal congestion by inducing vasoconstriction of nasal mucosal blood vessels. The synergistic action of these active ingredients makes Winituss-DMR Tablet an effective therapeutic option for managing cough, congestion, mucus hypersecretion, and allergic manifestations. It is recommended to be used under medical supervision, with caution advised in patients with hypertension, cardiac disorders, or hypersensitivity to any component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Winituss-DMR Tablet

Ambroxol (30mg/5ml) + Cetirizine (5mg/5ml) + Dextromethorphan Hydrobromide (10mg/10ml) + Guaifenesin (100mg/5ml) + Phenylephrine (15mg/5ml)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+4 more active ingredients
Dextromethorphan acts on the cough center in the brain, reducing the urge to cough.
Ambroxol stimulates the secretion of mucus and reduces its viscosity, facilitating easier expectoration.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Cetirizine acts as a competitive antagonist of histamine H1 receptors, thereby reducing the effects of histamine and alleviating allergic symptoms.
Guaifenesin reduces mucus viscosity by increasing the hydration of secretions in the respiratory tract, facilitating easier expectoration.
Medical applications
Winituss-DMR Tablet is a combination medication formulated to provide comprehensive relief from symptoms associated with respiratory tract infections and allergic conditions. It contains Ambroxol (30mg/5ml), a mucolytic agent that facilitates the breakdown and clearance of mucus, thereby improving airway patency. Cetirizine (5mg/5ml), a second-generation antihistamine, effectively alleviates allergic symptoms such as sneezing, runny nose, and itching by selectively inhibiting peripheral H1 receptors. Dextromethorphan Hydrobromide (10mg/10ml) acts as a centrally acting antitussive, suppressing the cough reflex to reduce the frequency and severity of dry, non-productive cough. Guaifenesin (100mg/5ml) serves as an expectorant, promoting the loosening and expulsion of mucus from the respiratory tract, enhancing productive cough. Phenylephrine (15mg/5ml), a selective alpha-1 adrenergic receptor agonist, provides symptomatic relief from nasal congestion by inducing vasoconstriction of nasal mucosal blood vessels. The synergistic action of these active ingredients makes Winituss-DMR Tablet an effective therapeutic option for managing cough, congestion, mucus hypersecretion, and allergic manifestations. It is recommended to be used under medical supervision, with caution advised in patients with hypertension, cardiac disorders, or hypersensitivity to any component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Winituss-DMR Tablet















